Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.60
Bid: 18.60
Ask: 18.98
Change: -0.07 (-0.37%)
Spread: 0.38 (2.043%)
Open: 20.00
High: 20.00
Low: 18.60
Prev. Close: 18.86
NANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Year End Trading Update and Notice of Results

15 Aug 2018 07:00

RNS Number : 8174X
Nanoco Group PLC
15 August 2018
 

15 August 2018

NANOCO GROUP PLC

("Nanoco" or the "Company")

 

Year End Trading Update

 

Notice of Results

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nano-materials, today provides the following year end trading update ahead of the announcement of its final results for the year to 31 July 2018, which will be released on 16 October 2018.

 

Highlights of the year include:

 

· Nano-materials:

o Steady progress has been made in the execution of the Material Development and Supply Agreements, announced in February and April 2018 with a large, undisclosed US listed corporation ('the Partner').

 

o The new manufacturing facilities in Runcorn are progressing as planned. Small-scale commercial shipments are expected to commence in calendar Quarter 4, 2018 and volume production is expected to commence in the second half of calendar 2019. H1 2019 calendar year will be utilised to stress test and improve the new Runcorn facility.

 

· Display:

o Nanoco continues to make progress in display, initially with gaming monitors. Nanoco's patented CFQD resin is being provided to Wah Hong to convert into film for a Taiwanese display panel maker. These gaming monitors are on track to launch to the public for the 2018 end of year holiday season.

 

· Financial:

o The Company's unaudited cash position at 31 July 2018 has increased by £2.0m to £10.7m since 31 January 2018 (31 January 2018: £8.7m; 31 July 2017: £5.7m).

 

o Unaudited revenues for the year ended 31 July 2018 of up to £2.5m arising from the first agreement with the Partner based on management's assessment that the project will be complete by 31 December 2018. This assessment will be confirmed prior to the release of the Preliminary Results and revenue will be adjusted accordingly if required. Revenues from other agreements and sales during the year amounted to c. £0.8m. As a result, unaudited revenues are expected to be up to £3.3m (31st July 2017 £1.3m).

 

o £8m net proceeds from November 2017 fundraise.

 

 

Executive team reorganisation

 

During the period, Nanoco successfully implemented a structured reorganisation of its executive team, combining its Chief Financial Officer and Chief Operating Officer positions into one unified role, and appointing Brian Tenner to this new position, effective from 20 August 2018. Current Chief Financial Officer David Blain will step down from his position on 20 August, and will remain with Nanoco until 15 October 2018 to facilitate an orderly handover of his duties.

 

Michael Edelman, Chief Executive of Nanoco, said:

 

"The second half of 2018 has been transformational for Nanoco with the signing of the development and supply agreement with our large US-listed partner in our nano-materials division. We have made meaningful progress in display and lighting with first commercial products expected later this calendar year. Our cash position has improved since last reporting and we start the new financial year with considerable confidence."

 

- Ends -

 

 

For further information, please contact:

Nanoco

Tel: +44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer

Chris Richards, Non-Executive Chairman

Caroline Watson, Investor Relations Manager

Tel: + 44 (0) 7799 897357

cwatson@nanocotechnologies.com

 

MHP Communications

Tel: +44 (0) 20 3128 8570

Reg Hoare / Giles Robinson / Pete Lambie

nanoco@mhpc.com

 

The information contained within this announcement constitutes inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014.

 

Notes for editors:

 

About Nanoco Group plc

Nanoco (LSE: NANO) harnesses the power of nano-technology to create a brighter, more sustainable future. Based on breakthrough science, Nanoco's proprietary manufacturing process enables the large-scale production of its cadmium-free CFQD® quantum dots for multiple applications including LCD display, lighting, healthcare, nano-materials and solar.

Nanoco has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany and Wah Hong Industrial Corporation of Taiwan.

Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.

Nanoco is listed on the Main Market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com. 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUSRARWAAWAUR
Date   Source Headline
16th Aug 20227:00 amRNSTrading Update
28th Jul 202210:42 amRNSHolding(s) in Company
13th Jul 20222:03 pmRNSReplacement - Director/PDMR Shareholding
13th Jul 202212:00 pmRNSHolding(s) in Company
13th Jul 202212:00 pmRNSDirector/PDMR Shareholding
13th Jul 202212:00 pmRNSHolding(s) in Company
30th Jun 20227:00 amRNSTotal Voting Rights
29th Jun 20227:00 amRNSChange of Auditor
23rd Jun 20223:48 pmRNSDirector/PDMR Shareholding
22nd Jun 20222:25 pmRNSHolding(s) in Company
21st Jun 20223:36 pmRNSDirector/PDMR Shareholding
21st Jun 20229:06 amRNSReplacement: Director/PDMR Shareholding
21st Jun 20227:00 amRNSDirector/PDMR Shareholding
17th Jun 20224:36 pmRNSPrice Monitoring Extension
17th Jun 202210:45 amRNSHolding(s) in Company
14th Jun 20229:42 amRNSHolding(s) in Company
9th Jun 20227:00 amRNSBlock listing Six-monthly Return
8th Jun 202212:00 pmRNSResults of Fundraise
8th Jun 20227:00 amRNSFundraise significantly over-subscribed
7th Jun 20225:16 pmRNSReplacement: Litigation Update
7th Jun 20224:55 pmRNSLitigation Update
6th Jun 20227:02 amRNSTrading Update & Proposed Fundraise
6th Jun 20227:00 amRNSMajor Work Package for European Customer
23rd May 20225:00 pmRNSHolding(s) in Company
17th May 20227:02 amRNSLitigation Update
13th May 202212:15 pmRNSHolding(s) in Company
13th Apr 20222:49 pmRNSHolding(s) in Company
12th Apr 20227:00 amRNSInterim Results
17th Mar 20227:00 amRNSAdditional Work Package for European Customer
15th Mar 20227:00 amRNSNotice of Interim Results
4th Feb 20223:14 pmRNSHolding(s) in Company
31st Jan 20227:00 amRNSTotal Voting Rights
9th Dec 20217:00 amRNSBlock listing Six-Monthly Return
2nd Dec 20217:18 amRNSBlock Listing Application
1st Dec 202112:30 pmRNSDirector/PDMR Shareholding
1st Dec 202112:28 pmRNSAnnual General Meeting – Voting Results
30th Nov 20217:00 amRNSAGM Statement
18th Nov 20211:13 pmRNSDirector/PDMR Shareholding
9th Nov 20217:11 amRNSDirector/PDMR Shareholding
8th Nov 20217:00 amRNSDirector Appointment
5th Nov 202111:25 amRNSAdditional Work Package for European Customer
4th Nov 20216:20 pmRNSNotice of AGM
3rd Nov 20217:00 amRNSPreliminary Results
18th Oct 20216:10 pmRNSChange to final results announcement date
13th Oct 20219:30 amRNSPresentation via Investor Meet Company
8th Oct 20211:48 pmRNSNotice of Results
19th Aug 20217:00 amRNSNon-Executive Director Appointment
16th Jul 20214:41 pmRNSSecond Price Monitoring Extn
16th Jul 20214:35 pmRNSPrice Monitoring Extension
15th Jul 20217:00 amRNSNon-dilutive loan note subscription

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.